Company intelligence / Profile preview

OrtoWay

Horsham, Pennsylvania, USAortoway-usa.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company’s flagship product, the OrtoWell® Distractor, is FDA-approved as a Class 1 medical device and has been used in over 50 surgeries worldwide. It is recognized for enabling safer and more controlled vertebral separation during anterior and lateral spinal surgeries. The system received a U.S. patent in July 2024 for its application in corpectomy procedures and was awarded “Most Advanced Separation System” by Global Health & Pharma Magazine in 2020[1][2][7].

Therapeutic areas: OtherOncologyNeurology
Modalities: Device (specifically, hydraulically powered surgical instrument)
Industry: Surgical Medical Devices

Partnerships

Seeking commercialization partners; no major pharma/biotech partnerships publicly disclosed

Beyond the preview

Go deeper on OrtoWay.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OrtoWay.

Explore the full profile